Zivo Bioscience
(ZIVO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,885 | -5,851 | -4,211 | -13,385 | -11,784 |
| Depreciation Amortization | N/A | -15 | 2,523 | 98 | N/A |
| Accounts receivable | 2 | -32 | 2 | 2 | -24 |
| Accounts payable and accrued liabilities | 584 | 189 | -87 | -424 | -242 |
| Other Working Capital | 936 | 284 | -343 | -501 | -429 |
| Other Operating Activity | 3,188 | 3,519 | 685 | 9,896 | 9,070 |
| Operating Cash Flow | $-2,173 | $-1,907 | $-1,430 | $-4,314 | $-3,408 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 488 | N/A | 488 | 518 | 518 |
| Debt Issued | 250 | 488 | N/A | N/A | N/A |
| Debt Repayment | -104 | -264 | -34 | -21 | N/A |
| Common Stock Issued | 395 | 150 | N/A | 5,602 | 3,178 |
| Other Financing Activity | -342 | 0 | -49 | -518 | -403 |
| Financing Cash Flow | $688 | $374 | $405 | $5,582 | $3,293 |
| Beginning Cash Position | 1,542 | 1,542 | 1,542 | 274 | 274 |
| End Cash Position | 57 | 10 | 517 | 1,542 | 159 |
| Net Cash Flow | $-1,485 | $-1,533 | $-1,025 | $1,268 | $-115 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,173 | -1,907 | -1,430 | -4,314 | -3,408 |
| Free Cash Flow | -2,173 | -1,907 | -1,430 | -4,314 | -3,408 |